USD
Links
0item(s)
Start typing to see products you are looking for.
2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone, 98%|975764|55094-52-5

2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone, 98%

Cat. No JK975764_100_G
J&K Chemical

Product Information

Product Name
2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone, 98%
Brand Name
J&K
Product Number
975764
CAS
55094-52-5
Molecular Formula
C26H26O5
Molecular Weight
418.48
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
11004289
IUPAC Name
(3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-one
InChI Key
LDHBSABBBAUMCZ-UBFVSLLYSA-N
SMILES
C1=CC=C(C=C1)COCC@@H2C@H(C@H(C(=O)O2)OCC3=CC=CC=C3)OCC4=CC=CC=C4

Safety Information

GHS Symbols
Hazard Symbol
Signal Word
Warning
Hazard Statement
H317
H319
Precautionary Statement
P261
P272
P280
P321
P501
P302+P352
P333+P317
P362+P364
P264+P265
P305+P351+P338
P337+P317

References

Improved Flow Synthesis of Remdesivir
Publication Name: Synfacts
Publication Date: 2021-04-20
DOI: 10.1055/s-0040-1719807

Synthesis of a Remdesivir Intermediate
Publication Name: Synfacts
Publication Date: 2020-11-17
DOI: 10.1055/s-0040-1706389

Methods of Synthesis of Remdesivir, Favipiravir, Hydroxychloroquine, and Chloroquine: Four Small Molecules Repurposed for Clinical Trials during the Covid-19 Pandemic
Publication Name: Synthesis
Publication Date: 2020-09-11
DOI: 10.1055/s-0040-1707386

Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections
Publication Name: Synfacts
Publication Date: 2020-06-17
DOI: 10.1055/s-0040-1707019

Remdesivir
Publication Name: Pharmaceutical Substances
Publication Date: 2020

2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone, 98%

Related Product

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page